Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data

Case studies
Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Building a comparative evidence base using network meta-analysis
Methods, implementation and reporting

Download 2025 Global and China biotech sector survey reports
Two new reports of surveys of 260+ Global and China biotech leaders have just been released

From bottlenecks to breakthroughs
Human-centred strategies for faster study starts
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.

Riding the data wave: How pharma can navigate disruptions in open claims
Watch the webinar.
About ICON

About ICON

Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, charity, inclusion and belonging
ICON Cares is our commitment to making a positive impact on our people, environment and our community.

ICON at a glance
Delivering successful outcomes across the clinical development lifecycle.

Careers
Investors
Contact
日本語
简体中文

Home
News & Events
Social media

Social media

Showing 673 - 684 of 955 results for "*"

In today’s data-rich healthcare landscape, life sciences leaders no longer need to choose between open or closed claims. Integration is the key to unlocking complete, representative, and actionable insights across payer,...

15 Oct

ICON Plc

Nearly 30% of the world’s data comes from healthcare—and for life sciences companies, that’s a huge opportunity. But to unlock its full potential, integration is key. Symphony Health, an ICON plc company, is leading the...

15 Oct

ICON Plc

Our ICON team in Lima recently came together for a Family Day with purpose - planting trees in the Ate district to support a greener, healthier local community. Events like these reflect what we value most at ICON: team...

14 Oct

ICON Plc

Join us at ACoP 2025 for two in-person workshops on October 17th, designed to help you build confidence and gain practical tools for delivering impactful NONMEM presentations. Workshop 1 : New and advanced features of N...

The therapeutic landscape for obesity is changing rapidly. Endpoints focused only on weight loss are no longer enough, and regulators expect measures that capture the entire patient experience. Watch our recent webinar t...

We are proud to share that ICON has been recognised among the Forbes World’s Top Companies for Women 2025. This recognition reflects our continued commitment to creating an inclusive workplace where women can thrive, lea...

Are you navigating complex IRT challenges or planning your next clinical trial? ICON’s experts will be onsite and ready to meet with pharma and biotech leaders looking to optimise their IRT strategy. Whether you're explo...

14 Oct

ICON Plc

USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences...

14 Oct